missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ C/EBP beta Monoclonal Antibody (3H9)
Description
MA5-15893 targets CEBPB in indirect ELISA, FACS and WB applications and shows reactivity with Human samples. The MA5-15893 immunogen is purified recombinant fragment of human CEBPB expressed in E. Coli. MA5-15893 detects CEBPB which has a predicted molecular weight of approximately 36kDa.
This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it may play a role in the development of mesenchymal tissues.
Specifications
Specifications
| Antigen | C/EBP beta |
| Applications | ELISA, Flow Cytometry, Western Blot |
| Classification | Monoclonal |
| Clone | 3H9 |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | Ascites with 0.03% sodium azide |
| Gene | Cebpb |
| Gene Accession No. | P17676 |
| Gene Alias | AGP/EBP; C EBP; c/EBP beta; C/EBPb; C/EBPbeta; C/EBP-beta; C/EBP-related protein 2; CCAAT enhancer binding protein beta; CCAAT/enhancer binding protein (C/EBP), beta; CCAAT/enhancer binding protein beta; CCAAT/enhancer-binding protein beta; CEBPB; Crp2; Il6dbp; IL-6DBP; interleukin 6-dependent DNA-binding protein; interleukin-6-dependent-binding protein; LAP; LIP; Liver activator protein; Liver-enriched inhibitory protein; Liver-enriched transcriptional activator; Nfil6; Nf-il6; NF-M; nuclear factor NF-IL6; nuclear factor of interleukin 6; nuclear factor-IL6; nuclear protein Il6; OTTMUSP00000017503; PP9092; Sfb; SF-B; Silencer factor B; TCF5; TCF-5; transcription factor 5; transcription factor C/EBP beta |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?